Search clinical trials for: deferasirox FCT

Total 164 results

Novartis Pharmaceuticals

Completed

Study to Evaluate the Efficacy and Safety of Deferasirox Film-coated Tablet Versus Phlebotomy in Patients With Hereditary Hemochromatosis (HH)

Hereditary Hemochromatosis

Belgium, France, Russian Federation, Romania, Slovakia, Spain, Switzerland
Fondazione Italiana Sindromi Mielodisplastiche-ETS

Terminated

Early and Low Dose Deferasirox (3.5 mg/kg FCT) to Suppress NTBI and LPI as Early Intervention to Prevent Tissue Iron Overload in Lower Risk MDS

Myelodysplastic Syndromes

Italy
Novartis Pharmaceuticals

Completed

Open-label, Multicenter Study Assessing Preference for Deferasirox Film-coated Tablet Compared to Dispersible Tablet (Jupiter)

Non-transfusion-dependent Thalassemia | Transfusion-dependent Thalassemia

Egypt, Turkey, Thailand, Lebanon, Morocco, Saudi Arabia, Vietnam
Novartis Pharmaceuticals

Completed

Extended Evaluation of Deferasirox Film-coated Tablet (FCT) Formulation

Chronic Iron Overload

Austria, Italy, Greece
Novartis Pharmaceuticals

Completed

Combination Study of Deferasirox and Erythropoietin in Patients With Low- and Int-1-risk Myelodysplastic Syndrome.

Low and Int 1-risk Myelodysplastic Syndrome

Germany, Canada, Korea, Republic of, Sweden, Spain, China, Argentina, Italy, United Kingdom, Algeria
Novartis Pharmaceuticals

Completed

Phase II Study to Investigate the Benefits of an Improved Deferasirox Formulation (Film-coated Tablet)

Chronic Iron Overload Due to Transfusion-dependant Anemias

Italy, Austria, Thailand, Spain, Germany, Mexico, Malaysia, Greece, United Kingdom, France, Saudi Arabia, United Arab Emirates, Lebanon, Russian Federation, United States, Argentina
Iscte-University Institute of Lisbon
University of Évora; Foundation for Science and Technology (FCT)

Recruiting

Sense to Act: An Interoceptive Sensibility Intervention for Musculoskeletal Pain

Musculoskeletal Pain | Chronic Pain

Portugal
International Bio service

Not yet recruiting

The Bioequivalence Study of Fixed-dose Combination of Vildagliptin and Metformin HCI 50/1000 mg FCT Under Fed Conditions

Healthy Volunteer
Paulista University

Not yet recruiting

Reliability and Performance Analysis of the Use of Tissue Flossing for Blood Flow Restriction.

Hypertrophy | Muscle Strength

Brazil
University of Minho
Foundation for Science and Technology (FCT)

Recruiting

The Brain, the Bug, and the Binge: the Interplay Between Binge Drinking, Gut Microbiota, and Brain Functioning

Binge Drinking

Portugal
Rutgers, The State University of New Jersey
Autism Speaks

Recruiting

Manualized Assessment and Treatment Model of Challenging Behavior

Aggression | Problem Behavior | Self-Injury

United States
Indiana University
BLES Biochemicals Inc.

Recruiting

Implementing LISA Surfactant in Nigeria

Respiratory Distress Syndrome | Neonatal Death

Nigeria
Boston University
Scleroderma Clinical Trials Consortium (SCTC); Fibrosis ARC: Connecting Tissues...

Recruiting

Longitudinal Spatial Frequency Domain Imaging Study (SFDI)

Systemic Scleroderma

United States
University of Minnesota
National Institute of Allergy and Infectious Diseases (NIAID)

Recruiting

Strategies and Treatments for Respiratory Infections & Viral Emergencies (STRIVE): Shionogi Protease Inhibitor (Ensitrelvir)

COVID-19

United States, Singapore, Japan, Ukraine, Georgia, Korea, Republic of, Australia, Denmark, Thailand, Greece, South Africa, Germany, Uganda, Spain, Puerto Rico, Argentina, Nigeria, United Kingdom
Universidade Nova de Lisboa
University Hospital, Geneva; NOVA Medical School; Administração Regional de Saúde... and other collaborators

Not yet recruiting

Multimorbidity Management Supported by a Digital Platform

Chronic Disease
University of Minho
Psychology Research Center (CIPsi); Psychology Association of the University... and other collaborators

Recruiting

Psychological Intervention for Child Mental Health Based on Parental Reflective Functioning to Enhance Positive Parenting (SK4Parenting+)

Externalizing Problems | Internalizing Problems

Portugal
Pfizer

Recruiting

A Study to Evaluate the Long-term Safety of Inclacumab Administered to Participants With Sickle Cell Disease

Sickle Cell Disease | Vaso-occlusive Pain Episode in Sickle Cell Disease | Vaso-occlusive Crisis

United States, Colombia, Brazil, Oman, Nigeria, Italy, Kenya, Lebanon, Turkey, Germany, Saudi Arabia, Tanzania
University of Pisa
IRCCS Burlo Garofolo; University of Genova

Recruiting

Risk Factors and Measures to Prevent Liver and Pancreas Complications in Pediatric Patients After HSCT

Iron Overload

Italy
Institute of Human Virology, Nigeria
University of Maryland, Baltimore; University of Pittsburgh; University of Georgia and other collaborators

Recruiting

Caregiver Peer Support and ART Adherence Among Children (CaPS)

HIV | Adherence

Nigeria
Rutgers, The State University of New Jersey

Recruiting

Refinements of Functional Communication Training

Aggression | Self-injurious Behavior

United States
University Hospital, Grenoble
Novartis

Recruiting

Evaluating Low-dose Deferasirox (DFX) in Patients With Low-risk MDS Resistant or Relapsing After ESA Agents (LODEFI)

Myelodysplasia

France
Novartis Pharmaceuticals

Completed

Survey to Assess Physicians' Knowledge of Exjade Posology and Biological Monitoring Recommendations as Described in the Educational Materials

Chronic Iron Overload

Switzerland
Pfizer

Active, not recruiting

Real World Utilization and Outcomes With Dacomitinib First Line Treatment for EGFR Mutation-positive Advanced Non Small Cell Lung Cancer Among Asian Patients - A Multi Center Chart Review

Lung Cancer

Malaysia
Haukeland University Hospital
Novartis

Withdrawn

Treatment of Iron Overload With Deferasirox (Exjade) in Hereditary Hemochromatosis and Myelodysplastic Syndrome (DefeHEMY)

Myelodysplastic Syndromes | Hemochromatosis

Norway
Novartis Pharmaceuticals

Completed

Study to Evaluate Treatment Compliance, Efficacy and Safety of an Improved Deferasirox Formulation (Granules) in Pediatric Patients (2-<18 Years Old) With Iron Overload

Transfusion-dependent Anemia

Egypt, Hungary, Turkey, United States, Bulgaria, Italy, Belgium, Russian Federation, Philippines, France, Malaysia, India, Oman, Panama, Lebanon, Thailand, Tunisia
Pfizer

Terminated

A Study of a Single Dose of Inclacumab to Reduce Re-admission in Participants With Sickle Cell Disease and Recurrent Vaso-occlusive Crises

Sickle Cell Disease | Vaso-occlusive Pain Episode in Sickle Cell Disease | Vaso-occlusive Crisis

United States, Oman, France, Brazil, Colombia, Lebanon, Nigeria, Germany, Italy, Kenya, Saudi Arabia, Turkey, United Kingdom, Zambia
University of Minnesota
National Health and Medical Research Council, Australia; Bristol-Myers Squibb; National Institutes of Health Clinical Center (CC) and other collaborators

Completed

Strategic Timing of Antiretroviral Treatment (START)

HIV Infection

Spain, United States, United Kingdom, Ireland, Australia, Argentina, Denmark, Sweden, Israel, Switzerland, Germany, Brazil, Norway, Chile, Thailand, Peru, Portugal, Greece, Luxembourg, Uganda, Austria, Belgium, Czechia, Estonia, Finland, ... and more
Pfizer

Active, not recruiting

A Study to Assess the Safety and Efficacy of Inclacumab in Participants With Sickle Cell Disease Experiencing Vaso-occlusive Crises

Sickle Cell Disease | Vaso-occlusive Pain Episode in Sickle Cell Disease | Vaso-occlusive Crisis

United States, Oman, France, Brazil, Colombia, Egypt, Nigeria, Lebanon, Germany, Italy, Kenya, Saudi Arabia, Tanzania, Turkey, Zambia, Ghana, United Kingdom
Boston Children's Hospital
Novartis

Completed

Pilot Study for Patients With Poor Response to Deferasirox

Sickle Cell Disease | Thalassemia Major | Transfusion-dependent Hemachromatosis

United States
Duke University

Active, not recruiting

FCT Study: Reducing the Need for Out-of-Home Placements (2018-0568)

Mental Disorder | Behavior Problem | Emotional Problem

United States
Aveiro University
Programa Operacional Inclusão Social e Emprego (POISE); Programa Operacional... and other collaborators

Completed

CENTR(AR): Lungs Moving (CENTR(AR))

Lung Diseases | Chronic Obstructive Pulmonary Disease | Pulmonary Disease | Interstitial Lung Disease | Chronic Respiratory Disease

Portugal
University of Maryland, Baltimore

Completed

Adolescent to Adult Patient-centered HIV Transition (ADAPT) Study (ADAPT)

HIV | AIDS

Nigeria
Washington University School of Medicine
University of Abuja Teaching Hospital

Completed

Feasibility and Acceptability of Risk Stratification in the Fourth Trimester to Reduce Maternal Morbidity and Mortality

Hypertensive Disorder of Pregnancy

Nigeria
Children's Hospital Los Angeles
Novartis Pharmaceuticals

Completed

Changes in Pituitary Iron and Volume With Deferasirox

Iron Overload

United States
Lundquist Institute for Biomedical Innovation at...
Novartis; Gilead Sciences; Astellas Pharma Inc

Completed

The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) Study

Mucormycosis

United States
University of Nebraska

Terminated

Treatment of Severe Destructive Behavior: FCT Versus Wait-List Control

Aggression | Self-Injurious Behavior

United States
Curemark

Completed

A Trial of CM-AT in Children With Autism With All Levels of FCT (The Blum Study)

Autism

United States
University of Coimbra
Foundation for Science and Technology (FCT)

Completed

HEPPI: Efficacy of a Cognitive-Emotional Intervention for Homebound Older Adults (HEPPI)

Depressive Symptoms | Mild Cognitive Impairment | Anxiety State

Portugal
Genuine Research Center, Egypt
Hikma Pharma

Completed

Bioequivalence Study of Solifenacin Succinate & Mirabegron From Mirfenacin MR 5/50 mg Extended Release Tablets (Hikma Pharma, Egypt) Versus Vesicare 5 mg FCT & Betmiga 50 mg Prolonged-Release Tablets (Astellas Pharma Europe B.V, the Netherlands / Astellas Pharma Europe B.V, the Netherlands)

Healthy

Egypt
Academisch Medisch Centrum - Universiteit van Amsterdam...

Completed

Low Dose Iron Chelation as TReatment of Oxidative Damage in Sickle Cell Disease (TROS)

Sickle Cell Disease

Netherlands
Center for Primary Care and Public Health (Unisante)...
Centre Hospitalier Universitaire Vaudois

Completed

Collaborative Seamless Care in Oncology : Measure and Reinforce Safety and Adherence to Oral Cancer Treatment

Cancer

Switzerland
NOVA School of Science and Technology ı FCT NOVA

Completed

Effects of a Scapular-focused Exercise Protocol

Rotator Cuff Syndrome of Shoulder and Allied Disorders

Portugal
University of Coimbra
Foundation for Science and Technology (FCT)

Completed

Homebound Elderly People Psychotherapeutic Intervention (HEPPI)

Depressive Symptoms | Mild Cognitive Impairment | Anxiety State

Portugal
Paulista University

Completed

Effects of Ischemic Preconditioning on Muscle Damage Induced by Excentric Exercise

Healthy

Brazil
Kenneth Myers, MD

Completed

Memantine for Epileptic Encephalopathy

Epileptic Encephalopathy, Childhood-Onset

Canada
DisperSol Technologies, LLC

Completed

Pilot Study to Assess the Safety, PK and Iron Chelating Activity of DST-0509 (Deferasirox) in Thalassemia Patients Refractory to Chelation

Thalassemia Major

Thailand, United States
Assiut University

Completed

Intracranial Collaterals in Acute Stroke and Clinical Outcome

Collateral Circulation, Any Site

Egypt
University of Abuja
Micronova Pharmaceuticals Ind Ltd

Completed

To Determine the Effect of Nebivolol on Office Blood Pressure of Blacks Residing in Nigeria (Nevibolol)

Hypertension

Nigeria
Novartis Pharmaceuticals

Completed

Study of Deferasirox for Treatment of Transfusional Iron Overload in Myelodysplastic Patients

Iron Overload | Myelodysplastic Syndrome

United States, Canada
Elliott Vichinsky

Completed

Combined Chelation Therapy in Patients With Transfusion Dependent Thalassemia and Iron Overload

Iron Overload | Thalassemia

United States

Search clinical trials for: deferasirox FCT

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Chile

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations